Hepatic adenomas

Analysis of sex steroid receptor status and the Wnt signaling pathway

Michael Torbenson, Jae Hyuk Lee, Michael Choti, Wesley Gage, Susan C. Abraham, Elizabeth Montgomery, John Boitnott, Tsung-Teh Wu

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Hepatic adenomas are strongly linked to excess hormonal exposure, but little else is known about their pathogenesis. The Wnt signaling pathway, which is activated in both hepatocellular carcinomas and hepatoblastomas, has not been studied in hepatic adenomas. Fifteen hepatic adenomas were studied by immunohistochemistry for estrogen, progesterone, and androgen receptors (ER, PR, AR, respectively) and correlated with the results of immunostaining for β-catenin. Direct sequencing was performed to look for mutations in key genes involved in the Wnt signaling pathway: Exon 3 of β-catenin encompassing the glycogen synthase kinase 3β (GSK-3β) phosphorylation region and the mutational cluster region of the adenomatosis polyposis coli protein (APC). Analysis for loss of heterozygosity (LOH) at chromosome 5q was also performed. Immunostaining for both ER and PR was present in 11/15 (73%) adenomas, and staining with one hormone receptor was positively associated with staining for the other receptor. AR positivity was present in 3/15 cases. Nuclear accumulation of β-catenin was present in 7/15 (46%) of adenomas, indicating activation of the Wnt signaling pathway. However, no β-catenin mutations, no APC mutations in the mutational cluster region, and no 5q LOH were detected. Two APC polymorphisms of unknown significance were seen. No clear association between β-catenin nuclear accumulation and hormone receptor positivity was discerned. Activation of the Wnt signaling pathway appears to be important in a subset of hepatic adenomas but does not result from common β-catenin or APC mutations and does not appear to be directly linked to hormonal receptor status.

Original languageEnglish (US)
Pages (from-to)189-196
Number of pages8
JournalModern Pathology
Volume15
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Catenins
Wnt Signaling Pathway
Steroid Receptors
Adenoma
Adenomatous Polyposis Coli
Liver
Mutation
Loss of Heterozygosity
Proteins
Staining and Labeling
Hepatoblastoma
Glycogen Synthase Kinase 3
Androgen Receptors
Progesterone Receptors
Cytoplasmic and Nuclear Receptors
Estrogen Receptors
Hepatocellular Carcinoma
Exons
Chromosomes
Immunohistochemistry

Keywords

  • β-catenin
  • APC
  • Estrogen
  • GSK-3β
  • Hepatic adenoma
  • Immunohistochemistry
  • Progesterone

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Torbenson, M., Lee, J. H., Choti, M., Gage, W., Abraham, S. C., Montgomery, E., ... Wu, T-T. (2002). Hepatic adenomas: Analysis of sex steroid receptor status and the Wnt signaling pathway. Modern Pathology, 15(3), 189-196. https://doi.org/10.1038/modpathol.3880514

Hepatic adenomas : Analysis of sex steroid receptor status and the Wnt signaling pathway. / Torbenson, Michael; Lee, Jae Hyuk; Choti, Michael; Gage, Wesley; Abraham, Susan C.; Montgomery, Elizabeth; Boitnott, John; Wu, Tsung-Teh.

In: Modern Pathology, Vol. 15, No. 3, 2002, p. 189-196.

Research output: Contribution to journalArticle

Torbenson, M, Lee, JH, Choti, M, Gage, W, Abraham, SC, Montgomery, E, Boitnott, J & Wu, T-T 2002, 'Hepatic adenomas: Analysis of sex steroid receptor status and the Wnt signaling pathway', Modern Pathology, vol. 15, no. 3, pp. 189-196. https://doi.org/10.1038/modpathol.3880514
Torbenson, Michael ; Lee, Jae Hyuk ; Choti, Michael ; Gage, Wesley ; Abraham, Susan C. ; Montgomery, Elizabeth ; Boitnott, John ; Wu, Tsung-Teh. / Hepatic adenomas : Analysis of sex steroid receptor status and the Wnt signaling pathway. In: Modern Pathology. 2002 ; Vol. 15, No. 3. pp. 189-196.
@article{815d325c91f940979a37feca6f39f1aa,
title = "Hepatic adenomas: Analysis of sex steroid receptor status and the Wnt signaling pathway",
abstract = "Hepatic adenomas are strongly linked to excess hormonal exposure, but little else is known about their pathogenesis. The Wnt signaling pathway, which is activated in both hepatocellular carcinomas and hepatoblastomas, has not been studied in hepatic adenomas. Fifteen hepatic adenomas were studied by immunohistochemistry for estrogen, progesterone, and androgen receptors (ER, PR, AR, respectively) and correlated with the results of immunostaining for β-catenin. Direct sequencing was performed to look for mutations in key genes involved in the Wnt signaling pathway: Exon 3 of β-catenin encompassing the glycogen synthase kinase 3β (GSK-3β) phosphorylation region and the mutational cluster region of the adenomatosis polyposis coli protein (APC). Analysis for loss of heterozygosity (LOH) at chromosome 5q was also performed. Immunostaining for both ER and PR was present in 11/15 (73{\%}) adenomas, and staining with one hormone receptor was positively associated with staining for the other receptor. AR positivity was present in 3/15 cases. Nuclear accumulation of β-catenin was present in 7/15 (46{\%}) of adenomas, indicating activation of the Wnt signaling pathway. However, no β-catenin mutations, no APC mutations in the mutational cluster region, and no 5q LOH were detected. Two APC polymorphisms of unknown significance were seen. No clear association between β-catenin nuclear accumulation and hormone receptor positivity was discerned. Activation of the Wnt signaling pathway appears to be important in a subset of hepatic adenomas but does not result from common β-catenin or APC mutations and does not appear to be directly linked to hormonal receptor status.",
keywords = "β-catenin, APC, Estrogen, GSK-3β, Hepatic adenoma, Immunohistochemistry, Progesterone",
author = "Michael Torbenson and Lee, {Jae Hyuk} and Michael Choti and Wesley Gage and Abraham, {Susan C.} and Elizabeth Montgomery and John Boitnott and Tsung-Teh Wu",
year = "2002",
doi = "10.1038/modpathol.3880514",
language = "English (US)",
volume = "15",
pages = "189--196",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Hepatic adenomas

T2 - Analysis of sex steroid receptor status and the Wnt signaling pathway

AU - Torbenson, Michael

AU - Lee, Jae Hyuk

AU - Choti, Michael

AU - Gage, Wesley

AU - Abraham, Susan C.

AU - Montgomery, Elizabeth

AU - Boitnott, John

AU - Wu, Tsung-Teh

PY - 2002

Y1 - 2002

N2 - Hepatic adenomas are strongly linked to excess hormonal exposure, but little else is known about their pathogenesis. The Wnt signaling pathway, which is activated in both hepatocellular carcinomas and hepatoblastomas, has not been studied in hepatic adenomas. Fifteen hepatic adenomas were studied by immunohistochemistry for estrogen, progesterone, and androgen receptors (ER, PR, AR, respectively) and correlated with the results of immunostaining for β-catenin. Direct sequencing was performed to look for mutations in key genes involved in the Wnt signaling pathway: Exon 3 of β-catenin encompassing the glycogen synthase kinase 3β (GSK-3β) phosphorylation region and the mutational cluster region of the adenomatosis polyposis coli protein (APC). Analysis for loss of heterozygosity (LOH) at chromosome 5q was also performed. Immunostaining for both ER and PR was present in 11/15 (73%) adenomas, and staining with one hormone receptor was positively associated with staining for the other receptor. AR positivity was present in 3/15 cases. Nuclear accumulation of β-catenin was present in 7/15 (46%) of adenomas, indicating activation of the Wnt signaling pathway. However, no β-catenin mutations, no APC mutations in the mutational cluster region, and no 5q LOH were detected. Two APC polymorphisms of unknown significance were seen. No clear association between β-catenin nuclear accumulation and hormone receptor positivity was discerned. Activation of the Wnt signaling pathway appears to be important in a subset of hepatic adenomas but does not result from common β-catenin or APC mutations and does not appear to be directly linked to hormonal receptor status.

AB - Hepatic adenomas are strongly linked to excess hormonal exposure, but little else is known about their pathogenesis. The Wnt signaling pathway, which is activated in both hepatocellular carcinomas and hepatoblastomas, has not been studied in hepatic adenomas. Fifteen hepatic adenomas were studied by immunohistochemistry for estrogen, progesterone, and androgen receptors (ER, PR, AR, respectively) and correlated with the results of immunostaining for β-catenin. Direct sequencing was performed to look for mutations in key genes involved in the Wnt signaling pathway: Exon 3 of β-catenin encompassing the glycogen synthase kinase 3β (GSK-3β) phosphorylation region and the mutational cluster region of the adenomatosis polyposis coli protein (APC). Analysis for loss of heterozygosity (LOH) at chromosome 5q was also performed. Immunostaining for both ER and PR was present in 11/15 (73%) adenomas, and staining with one hormone receptor was positively associated with staining for the other receptor. AR positivity was present in 3/15 cases. Nuclear accumulation of β-catenin was present in 7/15 (46%) of adenomas, indicating activation of the Wnt signaling pathway. However, no β-catenin mutations, no APC mutations in the mutational cluster region, and no 5q LOH were detected. Two APC polymorphisms of unknown significance were seen. No clear association between β-catenin nuclear accumulation and hormone receptor positivity was discerned. Activation of the Wnt signaling pathway appears to be important in a subset of hepatic adenomas but does not result from common β-catenin or APC mutations and does not appear to be directly linked to hormonal receptor status.

KW - β-catenin

KW - APC

KW - Estrogen

KW - GSK-3β

KW - Hepatic adenoma

KW - Immunohistochemistry

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=0036126892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036126892&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3880514

DO - 10.1038/modpathol.3880514

M3 - Article

VL - 15

SP - 189

EP - 196

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -